Assessing risk of fibrosis progression and liver-related clinical outcomes among patients with both early stage and advanced chronic hepatitis C.

Monica A KonermanDongxia LuYiwei ZhangMary ThomsonJi ZhuAashesh VermaBoang LiuNizar TalaatUlysses BalisPeter D R HigginsAnna S F LokAkbar K Waljee

Published in: PloS one (2017)

Accurate assessments for risk of clinical outcomes can be obtained using routinely collected data across a heterogeneous cohort of patients with CHC. These methods can be applied to predict risk of progression in other chronic liver diseases.

Keyphrases

early stage
liver fibrosis
electronic health record
big data
sentinel lymph node
radiation therapy
machine learning
drug induced
artificial intelligence